Rwanda Launches Africa's First Trial of Long-Acting Malaria Prevention Injection

Source: AllAfrica Global Media · 2026-11-06T12:23:02.000Z · Health

[Capital FM] Nairobi -- Rwanda has launched Africa's first clinical trial of a long-acting injectable drug for malaria prevention, marking a potential shift in how the disease is prevented as drug resistance and climate change threaten progress against the mosquito-borne illness.

This page presents the available publisher summary.